Preserve your uterus with scarless procedure
Imagine a life without fibroids!
Transforming women's health through empathetic innovation
Uterine fibroids are non-cancerous tumors affecting 1 in 4 women globally, causing substantial quality of life issues. Economic burden globally is about $34 Billion.
What we do
Nesa Medtech's mission is to transform women’s health by developing a revolutionary minimally invasive surgical solutions by pursuing innovation through technology while adhering to global quality standards with support of a multi disciplinary and experienced team.
Nesa’s flagship product GYIDE is a novel minimally invasive, safe, effective and uterus-preserving technology to treat uterine fibroids.
Existing Solutions - Invasive or Inaccessible
Cutting & Suturing
No Cut & Suture
Longer Procedure Time
GYIDE addresses the primary concern of key stakeholders and offers an effective alternative to current solutions.
Our innovative technology is a precise guidance and planning system to deliver treatment to shrink uterine fibroids leading to symptomatic relief.
Revolutionary scarless technology to treat uterine fibroids.
Less Procedure Time
No Cut, No Suturing
Strong and Prolonged
Primary Symptom Heavy menstrual bleeding²
Waiting time to seek treatment¹
Employed women missed work¹
1. Bijan J, Borah. Am J Obstet Gynecol 2013 Oct 209(4):319.e1-319.e2 2. De La Cruz MS, Buchana EM. Am Fam Physician 2017;95(2) 100-107